NCT00833196
Completed
Not Applicable
An International, Observational Study to Define Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia
ConditionsIdiopathic Cervical Dystonia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Idiopathic Cervical Dystonia
- Sponsor
- Ipsen
- Enrollment
- 404
- Locations
- 36
- Primary Endpoint
- Responder rate at peak effect following one BoNT-A injection cycle without any deviations from routine practice
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
A post marketing, international, multicenter, observational, prospective, longitudinal study. The purpose of the study is to describe cervical dystonia sub-types with their injection protocols and response to BoNT-A.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Idiopathic cervical dystonia
- •TWSTRS severity score ≥ 15
- •At least a 12-week interval between the last injection (BoNT-A or BoNTB) and inclusion
- •Written informed consent prior to collect the data
Exclusion Criteria
- •Contraindications to any BoNT-A preparations
- •Secondary cervical dystonia
- •Subject already been included in the study
Outcomes
Primary Outcomes
Responder rate at peak effect following one BoNT-A injection cycle without any deviations from routine practice
Time Frame: Around 4 weeks post injection
Secondary Outcomes
- To describe subject and investigator's CGI scores(Around 4 weeks post injection)
- To describe TWSTRS change scores from inclusion (total score & subscales scores)(Baseline, and around 4 weeks and 3 months post injection)
- To describe tremor change score from inclusion (TSUI scale)(Baseline, and around 4 weeks and 3 months post injection)
- To describe the Cervical Dystonia Impact Profile (CDIP) 58 change from inclusion(Baseline, and around 4 weeks post injection)
- To identify prognostic factors for response (Exploratory Objective)(baseline, and around 4 weeks and 3 months post injection)
Study Sites (36)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus DefectsPatent Ductus ArteriosusNCT05264753Occlutech International AB255
Completed
Not Applicable
Minima Clinical StudyTotal Hip ArthroplastyNCT02414542Limacorporate S.p.a80
Completed
Not Applicable
Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release Form in the Treatment of Egyptian Osteoarthritic PatientsOsteoarthritisPainMorning StiffnessNCT01226095Abbott519
Completed
Not Applicable
Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic ArthritisAnkylosing SpondylitisPsoriatic ArthritisNCT01474876AbbVie (prior sponsor, Abbott)566
Recruiting
Not Applicable
OSsIRIS Study - A Post-market Clinical Follow-up Investigation.Surgically Created Bone Defects or Bone Defects/Voids Resulting From Traumatic InjuryNCT06156904GreenBone Ortho S.p.A.135